ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,119Medicare Part D Prescriptions Filled, Including Refills

Rank: 113 out of 910

$721K Total Retail Price of All Prescriptions

Rank: 65 out of 910

992 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
6% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 992 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

7% of this provider’s 992 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 9,697 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

10 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 646 627 1 1
SIMVASTATIN 475 449 2 3
LISINOPRIL 376 370 3 2
OMEPRAZOLE 328 308 4 5
AMLODIPINE BESYLATE 306 291 5 4
ALENDRONATE SODIUM 218 213 6 22
ZOLPIDEM TARTRATE 211 196 7 17
METOPROLOL TARTRATE 207 201 8 7
ATORVASTATIN CALCIUM 198 187 9 14
LOSARTAN POTASSIUM 189 170 10 15
CITALOPRAM HBR 176 157 11 19
MELOXICAM 170 156 12 76
FUROSEMIDE 157 150 13 9
HYDROCODONE-ACETAMINOPHEN 157 157 S3 13 8
ATENOLOL 151 149 15 10
HYDROCHLOROTHIAZIDE 148 144 16 12
TRIAMTERENE-HCTZ 146 135 17 39
METFORMIN HCL 123 119 18 6
FLUTICASONE PROPIONATE 120 110 19 23
PRAVASTATIN SODIUM 119 111 20 16
CRESTOR 118 115 21 26
POTASSIUM CHLORIDE 117 116 22 18
TRAMADOL HCL 114 113 23 25
WARFARIN SODIUM 114 107 23 11
METOPROLOL SUCCINATE 111 108 25 21
LOSARTAN-HYDROCHLOROTHIAZIDE 103 101 26 79
AZITHROMYCIN 92 88 27 41
LISINOPRIL-HYDROCHLOROTHIAZIDE 86 86 28 44
SYNTHROID 80 77 29 54
CELEBREX 78 71 30 85
GABAPENTIN 77 77 31 13
DIOVAN HCT 71 70 32 133
LEVOXYL 71 70 32 106
LOVASTATIN 71 71 32 20
DONEPEZIL HCL 67 67 35 32
PANTOPRAZOLE SODIUM 66 61 36 27
CYMBALTA 63 58 37 58
TERAZOSIN HCL 62 62 38 61
GEMFIBROZIL 62 58 38 63
ACTONEL 59 57 40 102
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 58 41 134
CARVEDILOL 57 57 42 36
SERTRALINE HCL 56 56 43 24
DIOVAN 55 54 44 34
CIPROFLOXACIN HCL 55 52 44 48
EVISTA 52 52 46 139
ALLOPURINOL 51 51 47 33
OXYCODONE-ACETAMINOPHEN 50 50 S2 48 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 18, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.